IP Library Granted Patent US 9,175,019
Granted Patent B2
US 9,175,019 · App. 14/009,831 · Granted Nov 3, 2015

Industrial process for the preparation of N-alkyl-N-trialkylsilylamides

Inventors: Roland Callens (Tielt, BE); Andre Collin (Brussels, BE)
Assignee: PEPTISYNTHA SA
C07F7/0801C07F7/10C07K1/1077
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,175,019
App. No.
14/009,831
Granted
Nov 3, 2015
Kind
B2
Abstract

The present invention relates to a process for producing N-alkyl-N-trialkylsilylamides from trialkylsilylhalides and N-alkylamides in the presence of a base and in the absence of a solvent.

Claims (40)

1. A process for the preparation of a compound of formula

wherein R 1 , R 2 , R 3 , R 4 and R 5 independently of each other represent C 1 -C 6 alkyl,

comprising

reacting a compound of formula

wherein R 1 and R 2 are as defined above

with a compound of formula

wherein X represents a halogen and R 3 , R 4 and R 5 are as defined above,

in the presence of an organic base [OB] to form the compound of formula I and the salt of the protonated organic base [OB]H + X − , wherein X is as defined above and separating the compound of formula I from the salt of the protonated organic base [OB]H + X − , wherein the process is carried out in a reaction medium, wherein the compound of formula II, the compound of formula III, the organic base [OB] and the reaction products formed during the reaction are present in a combined amount of at least 90% of the reaction medium,

and

wherein 0.8 to 2 moles of the organic base [OB] are used per mole of the compound of formula II.

2. The process according to claim 1 , wherein about 1 mole of the organic base [OB] is used per mole of the compound of formula II.

3. The process according to claim 1 , wherein R 1 , R 2 , R 3 , R 4 and R 5 independently of each other represent C 1 -C 4 alkyl which can be identical or different.

4. The process according to claim 3 , wherein R 1 , R 2 , R 3 , R 4 and R 5 independently of each other represent C 1 or C 2 alkyl which can be identical or different.

5. The process according to claim 1 , wherein R 1 , R 2 , R 3 , R 4 and R 5 are the same.

6. The process according to claim 5 , wherein R 1 , R 2 , R 3 , R 4 and R 5 represent methyl.

7. The process according to claim 1 , wherein X represents chlorine.

8. The process according to claim 1 , wherein the organic base [OB] is a nitrogen containing organic base.

9. The process according to claim 1 , wherein the compound of formula I is separated from the salt of the organic base [OB]H + X − by adding an antisolvent for [OB]H + X − to the reaction medium so that the salt of the organic base [OB]H + X − precipitates and can be removed by filtration.

10. The process according to claim 9 , wherein the antisolvent is an alkane having a boiling point in the range from 35 to 80° C.

11. The process according to claim 1 , wherein the compound of formula II is reacted with the compound of formula III in a compound of formula II/compound of formula III molar ratio of 1/5 to 5/1.

12. The process according to claim 1 , wherein the reaction of the compound of formula II with the compound of formula III is carried out at a temperature in the range from 20 to 50° C.

13. A process for the manufacture of a peptide or peptide analogue which comprises

preparing a compound of formula I according to claim 1 ,

reacting the compound of formula I with an amino acid, a peptide or a peptide analogue to obtain a persilylated amino acid, peptide or peptide analogue, and

reacting the persilylated amino acid, peptide or peptide analogue with a compound of formula

Y-A-COOH  IV

 wherein Y is an amino protecting group, A is an amino acid, peptide or peptide analogue residue and COOH designates an optionally activated carboxylic group.

14. The process according to claim 1 , wherein the organic base [OB] is triethylamine.

15. The process according to claim 1 , wherein the compound of formula II is reacted with the compound of formula III in a compound of formula II/compound of formula III molar ratio of 1.5/1 to 1/1.

16. A process for the preparation of a compound of formula

wherein R 1 , R 2 , R 3 , R 4 and R 5 independently of each other represent C 1 -C 6 alkyl,

comprising

reacting a compound of formula

wherein R 1 and R 2 are as defined above

with a compound of formula

wherein X represents a halogen and R 3 , R 4 and R 5 are as defined above, in the presence of an organic base [OB] to form the compound of formula I and the salt of the protonated organic base [OB]H + X − , wherein X is as defined above and separating the compound of formula I from the salt of the protonated organic base [OB]H + X − , wherein the process is carried out in a reaction medium, wherein the compound of formula II, the compound of formula III, the organic base [OB] and the reaction products formed during the reaction are present in a combined amount of at least 90% of the reaction medium,

and

wherein about 1 mole of the organic base [OB] is used per mole of the compound of formula II, wherein about equimolar amounts of the compounds of formula III and the organic base [OB] are used and wherein compounds of formula II and III and the organic base [OB] are slowly added together.

17. The process according to claim 16 , wherein the compound III is added at a rate of 150 to 250 L/h to the mixture of compounds II and of the organic base.

18. The process according to claim 16 , wherein the compound II is added at a rate of 150 to 250 L/h to the mixture of compounds III and of the organic base.

Assignments (3)
CHANGE OF NAME Recorded Jan 23, 2017
From: PEPTISYNTHA
To: CORDEN PHARMA BRUSSELS PC
Reel/Frame 041051/0152 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2014
From: SOLVAY SA
To: PEPTISYNTHA SA
Reel/Frame 033642/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2014
From: CALLENS, ROLAND; COLLIN, ANDRE
To: SOLVAY SA
Reel/Frame 031903/0255 →
Priority Claims (1)
EP 11161122 · Apr 5, 2011 · regional
Continuity (1)
Related Publication 20140024805A1 · Jan 23, 2014